Search
for
Sort by
Research 511–540 of 1000+
- A systematic review of tumor necrosis factor-α blockers, anti-interleukins, and small molecule inhibitors for dissecting cellulitis of the scalp treatment
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Design of Nanocrystalline Suspension of Dutasteride for Intramuscular Prolonged Delivery
- Engineered Exosomes Biopotentiated Hydrogel Promote Hair Follicle Growth via Reprogramming the Perifollicular Microenvironment
- How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges
- Cellular therapeutics and immunotherapies in wound healing – on the pulse of time?
- The Role and Prospects of Mesenchymal Stem Cells in Skin Repair and Regeneration
- Recent progress of polymeric microneedle-assisted long-acting transdermal drug delivery
- Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends
- Repurposing of H1-receptor antagonists (levo)cetirizine, (des)loratadine, and fexofenadine as a case study for systematic analysis of trials on clinicaltrials.gov using semi-automated processes with custom-coded software
- Bibliometric analysis and visualization of research trends on HIV-1 capsid inhibitors (2000–2022)
- Targeted immunotherapy for hair regrowth and regeneration
- Liposome-Based Carriers for CRISPR Genome Editing
- Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review
- Transcranial focused ultrasound-mediated unbinding of phenytoin from plasma proteins for suppression of chronic temporal lobe epilepsy in a rodent model
- Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity
- Nanotechnological Interventions and Mechanistic Insights into Wound-Healing Events
- Antibody Drug Conjugates
- Acne Vulgaris
- Oral Presentations
- Hair & Cutaneous Development
- Clinical Evaluation of Intradermal Platelet Rich Plasma Administration along with Oral Biotin Supplement for the Management of Androgenetic Alopecia in Adult Males: A Randomised Clinical Tria
- Recent Advances in Understanding of the Etiopathogenesis, Diagnosis, and Management of Hair Loss Diseases
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- Shedding light on the FDA’s 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia
- FDA Reports of Alopecia as an Adverse Event to Isotretinoin
- FDA approves Pfizer's JAK inhibitor for adolescents with alopecia areata hair loss
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Are finasteride-related penile curvature/Peyronie’s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacovigilance databases
- FDA declines approval of testosterone drug for third time